11 February 2021>: Clinical Research
Risk Factors of Coronavirus Disease 2019-Related Mortality and Optimal Treatment Regimens: A Retrospective Study
Yuehong Wang 1BC* , Shuang Yao 2CDEF* , Xiaoling Liu 3BDEF* , Yinghao Cao 4ABCEF , Yaling Wang 5BF* , Mao Xie 6AEF*DOI: 10.12659/MSM.926751
Med Sci Monit 2021; 27:e926751
Table 2 The Clinical symptoms characteristics of the COVID-19 patients in the recovered and deceased groups.
Totaln=97 (%) | Recoveredn=76 (%) | Deceasedn=21 (%) | P* | |
---|---|---|---|---|
Fever | 0.801 | |||
No | 36 (37.11) | 29 (38.16) | 7 (33.33) | |
Yes | 61 (62.89) | 47 (61.84) | 14 (66.67) | |
Dry cough | 0.143 | |||
No | 55 (56.7) | 40 (52.63) | 15 (71.43) | |
Yes | 42 (43.3) | 36 (47.37) | 6 (28.57) | |
Expectoration | 0.999 | |||
No | 80 (82.47) | 63 (82.89) | 17 (80.95) | |
Yes | 17 (17.53) | 13 (17.11) | 4 (19.05) | |
Nasal congestion | 0.999 | |||
No | 89 (91.75) | 70 (92.11) | 19 (90.48) | |
Yes | 8 (8.25) | 6 (7.89) | 2 (9.52) | |
Headache | 0.287 | |||
No | 84 (86.6) | 64 (84.21) | 20 (95.24) | |
Yes | 13 (13.4) | 12 (15.79) | 1 (4.76) | |
Weak | 0.084 | |||
No | 47 (48.45) | 33 (43.42) | 14 (66.67) | |
Yes | 50 (51.55) | 43 (56.58) | 7 (33.33) | |
Myalgia | 0.287 | |||
No | 68 (70.10) | 51 (67.11) | 17 (80.95) | |
Yes | 29 (29.90) | 25 (32.89) | 4 (19.05) | |
Chest tightness | 0.453 | |||
No | 85 (87.63) | 65 (85.53) | 20 (95.24) | |
Yes | 12 (12.37) | 11 (14.47) | 1 (4.76) | |
Dyspnea | 0.643 | |||
No | 90 (92.78) | 71 (93.42) | 19 (90.48) | |
Yes | 7 (7.22) | 5 (6.58) | 2 (9.52) | |
Gasp | 0.999 | |||
No | 89 (91.75) | 69 (90.79) | 20 (95.24) | |
Yes | 8 (8.25) | 7 (9.21) | 1 (4.76) | |
Gastrointestinal symptoms | 0.999 | |||
No | 79 (81.44) | 62 (81.58) | 17 (80.95) | |
Yes | 18 (18.56) | 14 (18.42) | 4 (19.05) | |
* values were calculated by the Student’s t-test or Wilcoxon test for continuous variables. The Chi-square test for categorical variables, and the Fisher exact test was used when the data were limited. |